Aurora’s A1 Boxing is helping kids get off the streets and into the ring, and a city initiative is helping to fund it. It’s all part of Aurora’s goal to put an end to youth violence. Also on this week’s show, the Aurora Police Department launches a new high-tech way for residents to track crime…
Colorado-based biomaterials company GelSana Therapeutics has received seed equity funding from Mines Venture Fund I, which invests in startups led by Colorado School of Mines faculty, staff, alumni, students and formal partners. It’s the Mines Venture Fund’s first investment since it launched in December 2023.
“There is a lot going on in Colorado right now because of the tech hub designation,” said Laura Buccini, DrPH, MPH, MA, assistant vice chancellor for research development and strategy at the University of Colorado Anschutz Medical Campus. “But quantum sensing and quantum computing are things we’ve been talking about in medicine for years.” CU…
Johannes Fruehauf recognized a need for co-working laboratories — flexible rental lab spaces with shared equipment and consumables — a few years before he sold his first biotechnology spin-out company, Cequent Pharmaceuticals, based in Cambridge, Massachusetts, in 2010. At the time, he had started providing wet-lab consulting services to venture capitalists, so they could see…
Dive into the forefront of bioscience at the Fitzsimons Innovation Community Showcase, where groundbreaking advancements redefine health and life sciences. Bioscience companies from across the region showcased their advancements and discoveries on Sept. 27 at an event held at the Benson Hotel and Faculty Club and hosted by Fitzsimons Innovation Community and Aimco.
Staq Pharma Inc. opened its FDA-certified facility for pharmaceutical compounding and packaging in 2019 in Denver. The company plans a similar but larger facility in Columbus.
Fort Collins, CO, Nov. 30, 2023 (GLOBE NEWSWIRE) — Innosphere Ventures Fund is thrilled to announce a significant follow-on investment in GelSana, a groundbreaking company in the advanced wound care industry. GelSana has secured $3.1M to date in both dilutive and non-dilutive funding for its innovative hydrogel technology.
Exciting news from Lohocla Research Corporation! Lohocla, one of our member companies, has just announced the start of Phase 1 clinical trials for Kindolor, a pioneering non-addictive small molecule aimed at treating and preventing chronic pain disorders. This marks a crucial milestone in the journey toward a groundbreaking new treatment.
Aurora’s Innovation Campus houses dozens of biotech companies…
Life sciences hubs that include residential, retail and other commercial uses in addition to laboratory space are making their way to the Denver-Boulder market as developers look for ways to address headwinds from a tight labor market and a dearth of affordable housing in the area.